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Objectives: The management of combined carotid and coronary disease is controversial, and the outcomes of combined
carotid endarterectomy (CEA) and coronary artery bypass grafting (CABG) have not been determined on a community-
wide basis. This study was undertaken to evaluate the community-wide outcomes of combined CEA and CABG and to
evaluate the risk for adverse events.
Methods: A complete medical record review of 10,561 CEA procedures randomly selected from Medicare patients
undergoing CEA in 10 states was performed. In this sample, 226 procedures were performed in combination with CABG
in the same operative event.
Results: Recent ipsilateral stroke or transient ischemic attack was the indication for the CEA in only 12% of patients
undergoing CEA/CABG, and 56% were asymptomatic with respect to the carotid lesion. The combined stroke and death
rate was 17.7% (25 nonfatal strokes, two fatal strokes, and 13 nonstroke deaths). Eighty percent of the nonfatal strokes
were disabling. Proximal aortic arch atherosclerosis and symptomatic carotid stenosis were associated with stroke (P <
.05). Female gender, emergent operation, redo CABG, blood pressure on pump, total pump time, presence of left main
disease, and number of diseased coronaries were associated with mortality (P < .05). The strokes appeared to be
associated with the operative event, but diagnosis was delayed and postevent carotid patency was not documented. Most
strokes were not limited to the hemisphere ipsilateral to the CEA.
Conclusion: The community-wide outcomes of combined CEA/CABG in the Medicare population are inferior to those
reported in many single-institution reviews. Diagnosis of postoperative stroke is often delayed, and most strokes are not
limited to the hemisphere ipsilateral to the CEA operative site. (J Vasc Surg 2003;37:32-9.)
The management of concomitant severe atheroscle-
rotic disease in the carotid and coronary circulation is
difficult and controversial. Advanced coronary disease is
common in patients undergoing evaluation for carotid
endarterectomy (CEA). Hertzer et al1 have shown that 28%
of these patients have severe correctable coronary disease.
In addition, coronary artery disease is the leading cause of
both early and late mortality after CEA.2-4 Similarly, one of
the most concerning complications after coronary artery
bypass grafting (CABG) is stroke. Although all strokes after
CABG cannot be attributed to carotid disease, a significant
proportion of patients for CABG are found to have severe
carotid disease. It is estimated that up to 22% of patients
who undergo evaluation for CABG have 50% stenosis of
one or both carotid arteries and that 12% have stenoses
80%.5
Carotid endarterectomy for high-grade carotid lesions
is beneficial in reducing stroke,6,7 and CABG is effective in
reducing mortality from symptomatic coronary artery dis-
ease.8 However, the management of severe disease in both
the coronary and carotid circulations continues to be con-
troversial. Many reports in the literature support combined
CEA/CABG, reporting both low morbidity and low mor-
tality rates.9-21 These reports tend to involve multiyear case
series from centers of excellence. These centers are to be
commended; however, these reports do not necessarily
reflect community-wide outcomes of the combined proce-
dure. This report focuses on the outcomes of combined
CEA/CABG in a multistate population-based sample of
From the University of Chicago Robert Wood Johnson Clinical Scholars
Progama; the Division of Vascular Surgery, University of Iowab; and the
Iowa Foundation for Medical Care.c
Supported by the Iowa Foundation for Medical Care and the Robert Wood
Johnson Clinical Scholars Program.
Analyses on which this publication is based were performed under Contract
Number 500-99-IA03, entitled “Utilization and Quality Control Peer
Review Organization for the State of Iowa,” sponsored by the Centers for
Medicare and Medicaid Services, Department of Health and Human
Services. Content of this publication does not necessarily reflect the views
or policies of the Department of Health and Human Services, nor does
mention of trade names, commercial products, or organization imply
endorsement by the US Government.
The author assumes full responsibility for the accuracy and completeness of
the ideas presented. This article is a direct result of the Health Care
Quality Improvement Program initiated by the Centers for Medicare and
Medicaid Services, which has encouraged identification of quality im-
provement projects derived from analysis of patterns of care and therefore
required no special funding on the part of this contractor. Ideas and
contributions to the author concerning experience in engaging with issues
presented are welcomed.
Competition of interest: nil.
Presented at the Fiftieth Annual Meeting of the American Association for
Vascular Surgery, Boston, Mass, Jun 9-12, 2002.
Reprint requests: Kellie R. Brown, MD, 9200 W. Wisconsin Ave, Milwau-
kee, WI 53226 (e-mail: krbrown@mcw.edu).
Copyright © 2003 by The Society for Vascular Surgery and The American
Association for Vascular Surgery.
0741-5214/2003/$30.00  0
doi:10.1067/mva.2003.60
32
patients. In addition, the anatomic distribution of the
strokes and risk factors for stroke and mortality are defined.
METHODS
Population and data collection. A random sample of
10,561 CEA procedures (International Classification of
Diseases, Ninth Revision, Clinical Modification procedure
code of 38.12–endarterectomy of vessels of head and neck)
performed on patients with discharge dates between June
1, 1995, and May 31, 1996, was identified with the Medi-
care Provider Analysis and Review part A claims files from
Arkansas, Georgia, Illinois, Indiana, Iowa, Kentucky,
Michigan, Nebraska, Ohio, and Oklahoma. The sampling
procedure used to identify these 10,561 cases is described
elsewhere.22
Requests for copies of the entire medical record for the
primary admission and any readmissions were sent to the
hospitals. Compliance with these requests is mandated by
federal statute as part of participation in the Medicare
program. A data collection tool was created for medical
record abstraction by trained abstractors.
Each medical record was comprehensively reviewed to
determine patient demographics, the indication for the
procedure, perioperative care process, and postoperative
outcomes. The records were initially reviewed by trained
abstractors at a Centers for Medicare and Medicaid Services
Clinical Data Abstraction Center (DynKePRO, York, Pa).
Data were abstracted from medical records directly into a
computerized data entry system with an online edit check
and data definitions to improve accuracy of data collection.
In addition, the abstraction process underwent an extensive
validation procedure that is described elsewhere.22 The
medical records of all patients with strokes were indepen-
dently reviewed by two clinicians with expertise in CEA or
stroke to confirm the stroke and severity.
Within this sample of 10,561 patients, 226 patients that
had undergone both a CEA and a CABG procedure with
the same anesthetic were identified. The data from these
226 patients are analyzed for this report. In addition, the
medical records from 184 of these patients were available
and were rereviewed by one of the authors (KRB) for
further data abstraction. The additional data collected from
these 184 charts included information on comorbidities
(unstable angina, stable angina), anatomy (distribution of
coronary disease, percent carotid stenosis, proximal aortic
arch atherosclerosis), operative characteristics (urgent or
emergent indication, bypass pump time, lowest tempera-
ture and lowest mean blood pressure on pump, number of
coronary bypasses), and postoperative complications (ana-
tomic location of stroke, timing of stroke).
Definitions. Indications for CEA were classified into
four mutually exclusive categories. Patients were consid-
ered to have stroke as the indication for the procedure only
if they had documented ipsilateral hemispheric symptoms
that persisted for more than 24 hours within 90 days before
the procedure. Similarly, patients were considered to have
transient ischemic attack (TIA) as the indication only if
transient (24 hours) ipsilateral hemispheric symptoms
occurred within 90 days before the procedure and they did
not have a stroke within that same time period. Patients
were considered to be asymptomatic if there was no history
at any time before the procedure of cerebrovascular symp-
toms in either the anterior or posterior circulation. All
other patients (eg, those with remote ipsilateral symptoms,
global or vertebrobasilar symptoms, contralateral hemi-
spheric symptoms) were classified in a nonspecific category.
These definitions were used to create distinct stroke, TIA,
and asymptomatic indication groups with high reproduc-
ibility, given the limitations of retrospective medical record
review.
Patients were considered to have peripheral vascular
disease if a diagnosis of vascular disease in an arterial system
other than the coronary and carotid territories was re-
corded. Stable and unstable angina were considered to be
present if they were documented in the preoperative his-
tory. Coronary arteries were considered to be diseased if a
stenosis 70% was documented. The left main coronary
artery was considered diseased if 50% stenosis was docu-
mented. Patients were considered to have proximal aortic
arch atherosclerosis if a finding of an atherosclerotic prox-
imal aorta was noted on preoperative transesophogeal
echocardiogram or in the operative report. The operation
was said to be urgent or emergent if specifically stated such
by the operating surgeon or if the operation occurred
within 24 hours of cardiac catheterization for unstable
angina. Postreconstruction imaging included angiogram,
duplex scan, or continuous wave Doppler interrogation of
the CEA operative site.
For the purpose of outcome classification, a postoper-
ative stroke was considered to have occurred if any new or
worsening central nervous system deficit developed during
the postoperative period and persisted for more than 24
hours. Postoperative strokes were classified as major or
minor by looking at a point in time 5 days after the stroke or
at hospital discharge, whichever occurred sooner. If the
patient had a new persistent deficit that resulted in a need
for assistance with ambulation or eating or had significant
difficulty with speaking, the patient was considered to have
had a major stroke. Patients without disability at 5 days
after the event were considered to have had a minor stroke.
Deaths were considered stroke related if the death was
associated with a major stroke. If there was no evidence of
major stroke associated with the death, the death was
classified as non–stroke-related. The timing of the stroke
was defined by the earliest documentation of a new post-
operative deficit noted in the physician, nursing, or ancillary
care notes.
Data analysis. Simple descriptive statistics were used
to initially examine the data, including means and standard
deviations. The relationships between comorbid, anatomic,
or technical variables and the outcome variables of stroke,
mortality, and combined stroke and mortality were exam-
ined with 2 tests and t tests where appropriate. For vari-
ables that were significantly associated with stroke or death
in the univariate analysis, logistic regression controlling for
CEA indication was undertaken. An adjusted odds ratio
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was obtained and compared with the unadjusted odds ratio
obtained without controlling for CEA indication. Because
of the small number of outcomes, more extensive multivar-
iate logistic regression was not used.
RESULTS
Sixty-three percent of the patients were male, and the
average age of the population was 72.2 years. Sixty-six
percent of the patients had a history of tobacco use, and
76% had hypertension. Diabetes was present in 33%, and
peripheral vascular disease (other than carotid disease) was
present in 34%. A history of atrial fibrillation was present in
11%. Unstable angina was the presenting cardiac symptom
in 65%, and stable angina was the presenting symptom in an
additional 16%. Fig 1 shows the indications for CEA.
Asymptomatic carotid disease was the indication in 126 of
the patients (56%), and only 12% had a clear ipsilateral TIA
or stroke as the indication for CEA.
The degree of stenosis in both carotid arteries is seen
in Fig 2. These data come from the 184 charts that were
reabstracted. Eighty-seven percent of these patients had
an ipsilateral stenosis of 80%, and 20% of patients had
bilateral stenoses80%. Fig 3, which is also derived from
the reabstracted data, shows that most of these patients
did not have severe or symptomatic disease as the indi-
cation for CEA. Only 9% of these patients underwent
operation for a recent TIA or stroke, and only an addi-
tional 22% had bilateral severe disease or a contralateral
occlusion.
The overall combined stroke and mortality rate was
17.7%. This included 25 nonfatal strokes, two fatal strokes,
and 13 nonstroke deaths, for an overall stroke rate of 12%
and a mortality rate of 6.6%. Eighty percent of the nonfatal
strokes were disabling, meaning that the patient had a
persistent new deficit that significantly interfered with walk-
ing, talking, or eating 5 days after surgery or at discharge,
whichever came first.
The factors assessed for association with adverse out-
come are seen in Table I. Female gender, presence of left
main coronary artery disease, history of myocardial infarc-
tion, redo CABG, and emergent operation were signifi-
cantly associated with mortality. CEA indication was signif-
icantly associated with stroke. Patients with nonspecific
symptoms had a relative risk of 2.4 for stroke after the
combined procedure compared with asymptomatic pa-
tients. Patients with ipsilateral TIA as an indication had a
relative risk of 3.7, and patients with ipsilateral stroke as an
indication had a relative risk of 5.7 compared with asymp-
tomatic patients. In addition, the presence of proximal
aortic arch atherosclerosis conveyed a 4.4 times increased
risk of stroke. The severity of ipsilateral or contralateral
stenosis (80%) was not significantly associated with
stroke. Bilateral severe stenosis (80%) also was not signif-
icantly associated with a poor outcome. Occlusion con-
tralateral to the side of CEA trended toward a significant
association with stroke (P  .07). The use of a patch, a
shunt, or an intraoperative assessment of need for a shunt
was not shown to be protective against stroke or death in
our series, although there was a trend toward a benefit from
patching with the combined stroke/mortality outcome
(relative risk, .56; P  .09).
CABG operative factors are seen in Table II. The
number of diseased coronary arteries was higher in those
patients who died and trended towards a significant associ-
ation with stroke. None of the other operative factors were
significant, although the total time on pump and the lowest
blood pressure on pump trended towards significance, with
a P value of .053 in both cases.
Table III shows the results of the logistic regression for
those variables that were associated or possibly associated
with stroke in the univariate analysis. None of the odds
ratios changed significantly after adjustment for CEA indi-
cation, but the P value for contralateral occlusion becomes
somewhat larger, which removed the trend toward signifi-
cance.
Indepth analysis of the 19 strokes that had charts
available for review revealed that four were limited to the
side ipsilateral to the CEA, three were limited to the side
contralateral to the CEA, seven were limited to the poste-
rior circulation, and five were multifocal. These results are
seen in Fig 4. The timing of the first documentation of a
neurologic deficit was generally delayed. None of the
strokes were noted within the first 6 hours after surgery. Six
strokes were noted between 6 and 24 hours, and six strokes
were noted between 25 and 48 hours after surgery. Seven
strokes were not noted until after the second postoperative
day. There did not appear to be any association between the
anatomy of the stroke (ipsilateral, contralateral, posterior,
multifocal) and timing of documentation of the stroke. In
addition, there did not appear to be any association be-
tween the severity of the stroke and the timing of documen-
tation of the stroke. In only one case was carotid imaging
undertaken after the deficit was discovered, and the repair
was patent.
Fig 1. Indications for CEA.
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DISCUSSION
Much controversy has been seen with regard to the
combined CEA/CABG procedure. Proponents of the
combined approach quote low stroke rates (ranging
from 0 to 5.8%) and acceptable mortality rates (ranging
from 0 to 8.9%),9-21 although much higher stroke and
mortality rates, reaching 25% and 13%, respectively,23
have been reported. The stroke and mortality rates in the
largest series tend to be lower, and these series are often
from single institutions. One reason this study was un-
dertaken was to determine the outcome of combined
CEA/CABG in a population-based sample of patients.
Our cases were drawn from a large, randomly selected,
representative sample of Medicare patients from 10
states, which makes this sample more generalizable to
the greater population of all patients undergoing com-
bined CEA than a single institution series would be. In
this study, the stroke and mortality rates were 12% and
6.6%, respectively, with a combined stroke and mortality
rate of 17.7%. For comparison, the combined stroke and
mortality rate for those patients in the larger data set who
underwent CEA alone was 5.2%, as previously report-
ed.22 Thus, the stroke and mortality rates associated with
the combined procedure are much higher than with CEA
Fig 2. Carotid stenosis severity. I  80, Ipsilateral stneosis 80%; I  80, ipsilateral stenosis 80%; C  80,
contralateral stensosis 80%; C  80, contralateral stenosis 80%; C  100, contralateral occlusion.
Fig 3. Carotid stenosis and indication for endarterectomy. Recent TIA/stroke, Those patients with TIA or stroke
within 90 days before procedure as indication for CEA; bilat severe dz, those patients with bilateral carotid stenosis
80% without recent TIA or stroke; none of above, those patients who did not have recent TIA or stroke as CEA
indication and who did not have either bilateral 80% carotid stenoses or contralateral occlusion.
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alone. These rates are also high when compared with
combined CEA/CABG studies in the literature with
comparable numbers of patients.9,10,12,13,16,17,20,24 Our
stroke and mortality rates are higher even than Borger et
al25 found in a metaanalysis of 844 patients reported in
the literature. The high stroke and mortality rates in this
study are even more remarkable given the fact that most
patients were asymptomatic and had unilateral disease.
These findings suggest that surgeons contemplating a
combined procedure should determine their own success
Table I. Factors associated with stroke, mortality, or combined stroke/mortality
No. (%)
Stroke Mortality Combined stroke/mortality
Rate (%) RR (P value) Rate (%) RR (P value) Rate (%) RR (P value)
Comorbidities
Female gender 83 (36.7) 15.7 1.59 (.19) 12.0 3.45 (.01) 25.3 1.90 (.02)
Smoking history 149 (65.9) 11.4 0.88 (.73) 6.7 1.03 (.95) 16.8 0.86 (.61)
Diabetes 75 (33.2) 13.3 1.18 (.65) 5.3 0.73 (.58) 16.0 0.86 (.64)
History of MI 126 (55.8) 11.1 0.85 (.66) 9.5 3.17 (.05) 19.8 1.32 (.34)
History of HTN 172 (76.1) 14.0 2.51 (.10) 6.4 0.86 (.79) 19.2 1.48 (.30)
History of AFIB 23 (10.2) 13.0 1.10 (.86) 8.7 1.35 (.68) 21.7 1.26 (.59)
History of CHF 47 (20.8) 12.8 1.09 (.85) 6.4 0.95 (.94) 19.1 1.11 (.77)
Unstable angina* 120 (65.2) 10.8 1.15 (.76) 6.7 4.27 (.13) 16.7 1.52 (.30)
Stable angina* 30 (16.3) 6.7 0.60 (.47) 3.3 0.64 (.66) 10.0 0.64 (.43)
Carotid indication
Asymptomatic (reference) 126 (55.8) 6.3 1.00 8.7 1.00 13.5 1.00
Nonspecific symptoms 72 (31.9) 15.3 2.43 (.04) 2.8 0.32 (.10) 18.1 1.34 (.40)
Ipsilateral TIA 17 (7.5) 23.5 3.73 (.02) 11.8 1.35 (.68) 35.3 2.62 (.02)
Ipsilateral stroke 11 (4.8) 36.4 5.78 (.001) 0 – 36.4 2.70 (.04)
Carotid stenosis (80%)
Ipsilateral stenosis† 151 (86.8) 9.3 0.53 (.23) 4.6 0.53 (.41) 13.2 0.51 (.11)
Contralateral stenosis‡ 39 (25.5) 15.4 1.35 (.52) 2.6 0.42 (.39) 17.9 1.08 (.85)
Contralateral occlusion‡ 20 (13.1) 25.0 2.38 (.07) 0 - 25.0 1.58 (.31)
Bilateral stenosis§ 31 (20.7) 12.9 1.10 (.86) 3.2 0.55 (.56) 16.1 0.96 (.93)
CEA technique
Patch 77 (34.1) 7.8 0.55 (.17) 5.2 0.70 (.53) 11.7 0.56 (.09)
Shunt 118 (52.2) 12.7 1.14 (.71) 6.8 1.05 (.93) 17.8 1.01 (.97)
Monitor 47 (20.8) 17.0 1.60 (.23) 2.1 0.27 (.16) 19.1 1.11 (.77)
No monitor/no shunt 74 (32.7) 9.5 .72 (.42) 8.1 1.37 (.54) 17.6 0.99 (.97)
Proximal aortic atherosclerosis* 31 (16.8) 29.0 4.44 (.0002) 9.7 2.47 (.18) 35.5 3.39 (.0003)
Left main disease* 65 (35.3) 10.8 1.07 (.88) 9.2 3.66 (.04) 18.5 1.46 (.28)
Redo operations
Carotid 5 (2.2) 20.0 1.70 (.57) 0 – 20.0 1.13 (.89)
CABG 15 (6.6) 6.7 0.54 (.51) 26.7 5.12 (.001) 33.3 2.01 (.10)
Emergent operation* 15 (8.2) 20.0 2.11 (.20) 20.0 5.63 (.005) 33.3 2.56 (.03)
Postreconstruction imaging 49 (21.7) 10.2 0.82 (.67) 2.0 0.26 (.14) 12.2 0.64 (.26)
*N  184. These data come from reabstraction. There were only 184 charts available for review, including 19 strokes and nine deaths.
†N  174.
‡N  153.
§N  150. These data come from reabstraction, and there were some missing data in records.
RR, Relative risk; MI, myocardial infarction; HTN, hypertension; AFIB, atrial fibrillation; CHF, congestive heart failure.
Reference category for CEA indication is asymptomatic. Reference category for all other variables is patients without that particular characteristic.
Table II. CABG operative factors
Stroke
(n  19)
No stroke
(n  165) P value
Death
(n  9)
No death
(n  175) P value
No. of diseased coronaries 3.39 2.87 .056 3.67 2.89 .035
No. of bypasses 3.79 3.42 .15 3.33 3.46 .72
Pump characteristics
Total time on pump 116.8 103.2 .17 130.6 103.3 .053
Crossclamp time 71.3 62.5 .22 68.6 63.2 .59
Lowest temperature 28.93 29.65 .40 30.11 29.55 .66
Lowest blood pressure 53.83 54.99 .65 48.0 55.20 .053
N  184. These data come from reabstraction where there were only 184 charts available for review. There were 19 strokes and nine deaths in this subgroup
of 184.
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with the procedure rather than basing risk/benefit anal-
yses on the reported literature.
Another goal of this study was to determine those
factors that were associated with stroke or mortality. Prox-
imal aortic arch atherosclerosis was found to be significantly
associated with stroke even after controlling for CEA indi-
cation, which reflects the risk of atheroembolization when
clamping a diseased proximal aorta. This risk factor has
been previously described, both for isolated CABG and the
combined procedure.26-29 When the indication for the
CEA was symptomatic carotid disease, the patient also had
an increased risk of stroke. This risk increased with the
severity of the previous symptoms, such that previous
stroke conferred a higher risk than did TIA and TIA con-
ferred a higher risk than did nonspecific symptomotology.
This relationship has also been described previously, both
for isolated CEA and for the combined proce-
dure.18,21,30,31 Interestingly, severity of carotid disease and
contralateral occlusion were not found to be associated
with stroke risk. Our data set had a small number of
outcomes, and perhaps with more data, a significant finding
would have emerged. In addition, the use of a patch was
not found to be protective, although there was a trend
towards significance. Only 77 of the 226 patients under-
went patching, and it is again possible that with more data
a significant finding would have emerged.
The factors associated with 30-day mortality in this
study included reoperative CABG, urgent or emergent
operation, left main disease, number of diseased coronaries,
history of myocardial infarction, and female gender. Non-
elective surgery and reoperative surgery have long been
known to be risk factors for increased mortality, and the
findings here are not surprising. The nonelective condition
is generally unstable with a poor prognosis. In our study,
the nonelective status was always from cardiac instability or
the need for urgent cardiac revascularization. Given the
high risk associated with emergent CABG, it is advisable to
defer CEA for asymptomatic disease to a later operation in
this patient population. Left main coronary artery disease,
number of diseased vessels, and history of myocardial in-
farction are all well-described risk factors for mortality after
both isolated CABG and the combined procedure.21,32 It is
not surprising that those patients with a history of myocar-
dial infarction, severe left main disease, or diffuse coronary
disease are at a higher risk for mortality. Female gender has
been found to be a significant risk factor for mortality after
CABG and may reflect smaller vessel size or advanced
disease at the time of surgery.33,34
The third reason that this study was undertaken was to
determine the cause of strokes that occur after CEA/
CABG. We found that most strokes were not confined to
the side ipsilateral to the CEA and that five of 19 were
multifocal. Although the strokes appeared to have occurred
during surgery, the diagnosis was delayed because of per-
sistent intubation and sedation after the CABG procedure.
This finding, combined with the strong association of
proximal aortic arch atherosclerosis with postoperative
stroke, suggests that most strokes in this series were not
directly related to the CEA. It appears then that the pre-
vention of noncarotid related strokes with the use of epi-
aortic imaging before clamping, avoidance of aortic clamp-
ing or cannulation, and the use of the off-pump technique
may be more important than concomitant CEA in limiting
adverse neurologic events in this patient population.
Another interesting finding was that most patients in
this series were asymptomatic relative to their carotid dis-
ease. In fact, only 31% of patients in this series had either
recent symptoms or severe disease as the indication for the
endarterectomy. In addition, most infarcts were not limited
to the ipsilateral carotid territory and may have been unre-
lated to the CEA. It is possible then that many of these
patients could have undergone a staged procedure.
There are limitations to this study. The study is a
retrospective chart review, and therefore, our data collec-
tion depended on what was recorded legibly in the medical
Fig 4. Locations of postoperative infarcts.
Table III. Results of multivariate logistic regression for
stroke
Variable
OR
stroke
P
value
Adjusted
OR stroke
P
value
Carotid stenosis (80%)
Ipsilat stenosis 0.49 .24 0.55 .35
Contralateral stenosis 1.41 .52 1.08 .89
Bilateral stenosis 1.15 .81 0.81 .74
Contralateral occlusion 2.83 .07 2.48 .13
Carotid techniques
Patch 0.52 .17 0.48 .13
Shunt 1.17 .37 1.17 .70
Monitor 1.73 .23 1.7 .26
No monitor/no shunt 0.69 .42 0.69 .43
Redo CEA 1.88 .58 1.75 .63
Proximal aortic atherosclerosis 5.85 .001 5.35 .001
Postreconstruction imaging 0.80 .67 0.77 .62
Adjusted odds ratio is adjusted for carotid indication. Reference category for
each variable is all patients who do not have that particular characteristic.
OR, Odds ratio.
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record. This could possibly have led to an underestimation
of the stroke rate if strokes occurred but were not ade-
quately recorded in the medical record. It is unlikely that
major or disabling strokes would fail to be documented by
either physicians or nurses. Second, the actual number of
outcomes in this study was not sufficient to use multivariate
logistic regression to determine risk factors for stroke and
mortality after controlling for all baseline factors. This
leaves the possibility that some of our significant findings
are from confounding effects. A much larger study would
have to be undertaken to eliminate this limitation. We did
use limited multivariate regression to control for CEA
indication and found that our results did not change signif-
icantly, indicating that there was not a large confounding
effect of carotid indication on our results.
CONCLUSION
The overall stroke rate of 12% and the mortality rate of
6.6% in this study are higher than most case series with
similar numbers of patients. These results may more accu-
rately reflect the outcomes that can be expected in the usual
practice situation as opposed to most results reported in the
literature from single institution reviews. The low percent-
age of patients with clear carotid territory symptoms as an
indication for CEA in this series suggests that a combined
procedure may have been avoided in many of the patients.
Most of the strokes were not limited to the ipsilateral
carotid territory and therefore may have been unrelated to
the CEA. The association of stroke events with aortic arch
atherosclerosis may suggest embolism related to the CABG
as an important cause, and the implementation of tech-
niques aimed at preventing such embolization may be more
important than combined CEA/CABG in limiting the
adverse neurologic event rate associated with CABG in
patients with both carotid and coronary disease.
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DISCUSSION
Dr John J. Ricotta (Stony Brook, NY). I think there are
couple of points to be made. First, you found 226 patients in 10
states. How many of these patients were located in centers where
one would have expected a reasonable annual experience with
combined coronary and carotid disease? I think this is something
that we tend to see 15 or 20 or even 30 times a year. And like most
other procedures, the more often it is done, the better the results
are going to be.
I think the other comment is, there is another way to look at
your data. We have looked at this in a different way, looking at
isolated CABG patients versus combined CABG-carotid patients.
And all of the risk, both the mortality risk and the stroke risk, can
be completely predicted based on the preoperative characteristics
of the patient that is coming for CABG. So, there are several
models out there that show increased stroke risk with CABG alone
using most of these risk factors.
So, how do you know whether these patients would have been
better staged or whether they just have an inherent stroke risk
because of their atherosclerotic burden and whether you do the
carotid or whether you do not do the carotid is not going to make
a difference?
And finally, I am glad you presented this because I have been
trying to get people to do a randomized study for about 5 years and
maybe somebody will decide that they want to help me out and
answer this question.
Dr Kellie R. Brown. I cannot tell you how many of these
patients were done at a center that does a lot of these, nor can I tell
you the volume of these done at the centers in which these patients
were done. I do not have those data.
But I do agree, and the slide showing the literature results
supports this, that high volume centers have better outcomes. And
I think that has been shown with virtually almost any surgical
procedure. So, that is not really surprising.
I also agree that there is a need for a randomized trial in order
to answer the question as to whether or not patients should be
staged or which patients can be safely staged. Our statement in this
study that many of these patients could possibly have been staged
was based on the fact that the majority were asymptomatic and the
majority did not have either bilateral disease or recent symptoms as
an indication for the endarterectomy. The only way, really, to
answer which patients should be staged and which patients should
be done combined is to have a randomized trial.
Dr Matthew J. Dougherty (Philadelphia, Pa). Did you have
any information on who was performing the carotid procedure?
Was this performed by the cardiac surgeon in a majority of cases?
And did you have any information about operative time?
I would echo Dr Ricotta’s comments, since only a minority of
these strokes seem to be ipsilateral, it may just be that these patients
have diffuse atherosclerosis and are going to have strokes from the
cardiac procedure alone.
Dr Brown. I agree.
No, I do not have the information on who did the procedures
in terms of what their training was or what their specialty was.
I did not have operative time. I did have time on pump, and
time on pump was not significantly associated with stroke or death.
Dr James Watson (Seattle, Wash). I had a recent opportunity
to do a combined carotid-coronary bypass and was able to actually
complete the carotid using a regional anesthesia followed by a
general anesthetic for the coronary bypass, and it worked out quite
well. I just wonder whether any of your patients had a combined
regional-general anesthetic and wonder about your perspective
about the advisability of doing it that way?
Dr Brown. I read through every one of those operative notes,
and I do not recall that any of the patients done in that manner were.
I have never done that. The only time that I have done this
procedure, it has all been done under general anesthetic, and I
think that is a perfectly acceptable way to do it.
Dr R. Clement Darling III (Albany, NY). That was an
excellent discussion on a very difficult database you presented. The
question I have is, do you know what the mortality and the stroke
rate is for patients undergoing just the CABG in this group? Are
you just identifying a marker for bad outcomes, or are you identi-
fying a problem with the surgery independent of the combined
procedure? Since almost a quarter of the patients had ipsilateral
strokes, maybe the combined procedure is not the major contrib-
uting factor for the bad outcomes.
Dr Brown. No, I do not have the information on the CABG
patients that were done, the isolated CABG patients that were
done, in the same states.
Dr Peter R. F. Bell (Leicester, United Kingdom). We, in
fact, wrote a paper in the European journal just a few weeks ago
that confirms what you say, the risk of getting a stroke and death
from not doing a combined procedure is, in fact, very low. And
there is no indication at all, looking at the literature, for doing this
operation in these patients. And I think your view confirms that.
Just two questions. What do you mean by aortic atherosclero-
sis? In my experience, they have all got it.
And secondly, it is not surprising that the strokes were not
reported for 6 hours because most of the patients are on a ventila-
tor at that time. Could you confirm that?
Dr Brown. Yes, absolutely. My definition for aortic athero-
sclerosis was it had to be either documented with a preoperative
echo or it had to be documented in the surgeon’s operative note,
that there was aortic atherosclerosis present.
In the terms of the delay in diagnosis, it is true, most of these
patients are sedated, on a ventilator after surgery, and that is
primarily the reason why the strokes are not identified immediately
after surgery. Which only speaks to the point that the timeframe in
which they are not discovered is the same timeframe in which you
would wish to intervene if you thought this was a problem with the
carotid. So, postreconstruction imaging may help to identify those
patients who might benefit from an intervention within that peri-
operative period.
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